Median age, years (range) | 43 (17 - 88) |
---|---|
Male gender (%) | 25 (64.1) |
Hematological diagnosis: | Â |
AML (% AML with IFD in study period) | 12 (9.7) |
ALL (% ALL with IFD in study period) | 4 (3.8) |
Autologous transplants (% autologous HSCT recipients with IFD) | 1 (1.4) |
Allogenic transplants (% allogeneic HSCT recipients with IFD) | 10 (16.1) |
   - Neutropenia post-transplantation (% allogeneic HSCT recipients with IFD occurring during neutropenia) | 4 (6.5) |
   - GVHD (% allogeneic HSCT recipients with IFD occurring during GVHD) | 6 (9.7) |
Relapsed leukemia on salvage chemotherapy post-transplantation | 5 |
Others* | 7 |
Location of IFD: | Â |
Sinus (%) | 5 (12.8) |
Pulmonary (%) | 34 (87.2) |
Median serum galactomannan (range) for: | Â |
   - All IFD cases (n = 41) | 0.3 (0.1--4.3) |
   - All probable/definite aspergillosis cases (n = 26) | 0.6 (0.1--4.3) |